Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-8-25
|
pubmed:abstractText |
Measles causes serious morbidity in infants, with the highest risk among those who are 6 to 12 months of age. In the United States, measles vaccine has been given at age 12 to 15 months to minimize interference by passive antibodies and to achieve the high seroprevalence required for herd immunity. Infants of mothers with vaccine-induced immunity may lose passively acquired antibodies before 12 months, leaving them susceptible to measles infection.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0098-7484
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
280
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
527-32
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9707142-Age Factors,
pubmed-meshheading:9707142-Antibodies, Viral,
pubmed-meshheading:9707142-Antibody Formation,
pubmed-meshheading:9707142-Cohort Studies,
pubmed-meshheading:9707142-Cytokines,
pubmed-meshheading:9707142-Humans,
pubmed-meshheading:9707142-Immunity, Maternally-Acquired,
pubmed-meshheading:9707142-Infant,
pubmed-meshheading:9707142-Measles,
pubmed-meshheading:9707142-Measles Vaccine,
pubmed-meshheading:9707142-Measles virus,
pubmed-meshheading:9707142-T-Lymphocytes
|
pubmed:year |
1998
|
pubmed:articleTitle |
Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
|
pubmed:affiliation |
Department of Pediatrics, Stanford University School of Medicine, Calif 94305-5208, USA. drhayley@leland.stanford.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|